... (VX-770) was developed by Vertex Pharmaceuticals and will tackle the 'functional' defect. It has been tested on CF patients in the US who carry a genetic defect known as G551D. European trials are ...
... can identify which genes are being expressed and how strongly.
The researchers evaluated 18 CF patients who were suffering severe exacerbations of their disease. They withdrew blood before and after ...
... die from a cascade of damaging lung infections. Pathogenic bacteria such as Staphylococcus aureus weaken the CF patient, but it is the onset of P. aeruginosa infection that signals a dangerous turn.
... prognosis, according to research that asked 223 adult CF patients to assess their own health and well ... then followed them for 10 years. Patient outcomes were analyzed with respect to their initial self ...
... from infections of the pulmonary and sinonasal systems, aminoglycosides are commonly administered to CF patients because of the potent effect they have on bacteria. The treatment is considered so ...
... comfortable providing primary care to young adult CF patients, while 32 percent reported being ... be comfortable serving as the primary care provider for CF patients, while 35 percent said the same for ...
... normal lifespan.
"It's my hope to understand what is causing the exaggerated mucous production and secretion in CF patients," says Dr. Rozmahel. "From there, we can figure out ways to correct it."
... reduce the sticky mucus that plugs the lungs of CF patients, which leads to antibiotic-resistant infections ... normally destroyed it.
"Since this pivotal discovery of the CF gene nearly 20 years ago, ...
... published in the Sept. 26 issue of Science. CF is a common hereditary disease that affects multiple ... pancreas, liver, and gall bladder, similar to CF patients.
"Thus far, the clinical, physiological ...
... scientific opinion, progressive lung damage in CF patients can begin as early as infancy even ... nourished live longer," said Dr. Ranganathan. "[Those patients] should take manufactured pancreatic enzymes ...
... ' called the Burkholderia cepacia complex (Bcc) could have implications for the treatment of cystic fibrosis (CF) patients. CF patients produce large quantities of sticky mucus in their lungs that is ...
... a research associate. "It's an exciting translational framework that opens the door to potentially treating CF patients, taking the novel model we developed from the lab hopefully to the clinic."
Co ...
... vector systems suitable for delivering a corrected CF gene back into lung cells grown ... models of human lung cells derived from CF patients that recapitulate the architecture and function of the cells ...
... help researchers to develop novel therapies for improving the function of the diaphragm and other muscles in CF patients.
CF is a genetic disease caused by mutations in the CFTR gene. This gene is ...
... States (70,000 worldwide) suffer from CF. The disease results from a genetic alteration that lowers the ... lung, which leads to a dry lung. The drier a CF patient's lungs, the more dangerous his or her ...
